The stock of Opko Health Inc (OPK) has seen a -1.33% decrease in the past week, with a -0.67% drop in the past month, and a 10.45% flourish in the past quarter. The volatility ratio for the week is 6.00%, and the volatility levels for the past 30 days are at 4.45% for OPK. The simple moving average for the last 20 days is 0.10% for OPK stock, with a simple moving average of 13.43% for the last 200 days.
Is It Worth Investing in Opko Health Inc (NASDAQ: OPK) Right Now?
Additionally, the 36-month beta value for OPK is 1.64. There are mixed opinions on the stock, with 2 analysts rating it as a “buy,” 2 rating it as “overweight,” 2 rating it as “hold,” and 0 rating it as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for OPK is 325.95M and currently, short sellers hold a 28.51% ratio of that float. The average trading volume of OPK on November 05, 2024 was 3.16M shares.
OPK) stock’s latest price update
The stock price of Opko Health Inc (NASDAQ: OPK) has plunged by -1.99 when compared to previous closing price of 1.51, but the company has seen a -1.33% decline in its stock price over the last five trading sessions. zacks.com reported 2024-10-11 that OPKO Health’s receipt of the additional funding from BARDA is expected to explore the MSTAR platform to prepare for outbreaks and respond rapidly to emerging viral threats.
Analysts’ Opinion of OPK
Many brokerage firms have already submitted their reports for OPK stocks, with Barrington Research repeating the rating for OPK by listing it as a “Outperform.” The predicted price for OPK in the upcoming period, according to Barrington Research is $2 based on the research report published on June 29, 2023 of the previous year 2023.
H.C. Wainwright, on the other hand, stated in their research note that they expect to see OPK reach a price target of $3. The rating they have provided for OPK stocks is “Buy” according to the report published on December 15th, 2022.
OPK Trading at -3.14% from the 50-Day Moving Average
After a stumble in the market that brought OPK to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -15.19% of loss for the given period.
Volatility was left at 4.45%, however, over the last 30 days, the volatility rate increased by 6.00%, as shares surge +2.07% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -8.07% lower at present.
During the last 5 trading sessions, OPK fell by -1.33%, which changed the moving average for the period of 200-days by +48.45% in comparison to the 20-day moving average, which settled at $1.4785. In addition, Opko Health Inc saw -1.99% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at OPK starting from OPKO HEALTH, INC., who proposed sale 13,404 shares at the price of $40.88 back on Sep 17 ’24. After this action, OPKO HEALTH, INC. now owns shares of Opko Health Inc, valued at $547,956 using the latest closing price.
OPKO HEALTH, INC., the 10% Owner of Opko Health Inc, sale 50,000 shares at $34.49 during a trade that took place back on Aug 19 ’24, which means that OPKO HEALTH, INC. is holding 2,646,972 shares at $1,724,520 based on the most recent closing price.
Stock Fundamentals for OPK
Current profitability levels for the company are sitting at:
- -0.37 for the present operating margin
- 0.17 for the gross margin
The net margin for Opko Health Inc stands at -0.34. The total capital return value is set at -0.15. Equity return is now at value -16.59, with -11.75 for asset returns.
Based on Opko Health Inc (OPK), the company’s capital structure generated 0.13 points at debt to capital in total, while cash flow to debt ratio is standing at -0.31. The debt to equity ratio resting at 0.15. The interest coverage ratio of the stock is -16.73.
Currently, EBITDA for the company is -52.76 million with net debt to EBITDA at -1.34. When we switch over and look at the enterprise to sales, we see a ratio of 1.76. The receivables turnover for the company is 6.17for trailing twelve months and the total asset turnover is 0.36. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.63.
Conclusion
In conclusion, Opko Health Inc (OPK) has seen mixed performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
